73
Participants
Start Date
May 26, 2014
Primary Completion Date
January 31, 2017
Study Completion Date
September 25, 2017
AFLIBERCEPT
Irinotecan
5-Fluorouracil
Folinic Acid
2nd Dept of Internal Medicine, Agios Savvas Cancer Hospital, Athens
251 Airforce Hospital, Athens
"2nd Dept of Internal Medicine, General Hospital of Athens Hippokratio", Athens
Oncology Unit, 3rd Dept of Internal Medicine, Athens School of Medicine, Sotiria General Hospital, Athens
"Oncology Section, Dept of Clinical Therapeutics, General Hospital of Athens Alexandra", Athens
"Division of Oncology, 2nd Dept of Internal Medicine, University Hospital Attiko", Athens
2nd Dept of Medical Oncology, Agii Anargiri Cancer Hospital, Athens
3rd Dept of Medical Oncology, Agii Anargiri Cancer Hospital, Athens
3rd Dept of Medical Oncology, Hygeia Hospital, Athens
1st Dept of Medical Oncology, Metropolitan Hospital, Athens
2nd Dept of Medical Oncology, Metropolitan Hospital, Athens
Oncology Dept, University Hospital of Larissa, Larissa
Dept of Medical Oncology, Ioannina University Hospital, Ioannina
Dept of Medical Oncology, Papageorgiou General Hospital, Thessaloniki
Thermi Clinic S.A., Thermi
Dept of Medical Oncology, University Hospital of Heraklion, Heraklio
Agios Georgios Chania General Hospital, Chania
Division of Oncology, Dept of Internal Medicine, University Hospital of Patras, Pátrai
Collaborators (1)
Sanofi
INDUSTRY
Hellenic Cooperative Oncology Group
OTHER